decisionhealth Newsletters, Answer Books - 2009 Issue 3 (March)
Anti-Kickback Advisory Opinion Summaries / 2006 OIG Advisory Opinions / Opinion 06-05 - Research Organization May Provide Free Drugs, Supplies to Affiliates
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a 2006 Office of Inspector General advisory opinion about a nonprofit pediatric research organization and its regional affiliates. It explains the general structure of the arrangement, the compliance concern under the Anti-Kickback Statute, and the factors OIG discussed in evaluating the risk in the context of clinical research support. It is relevant to health care compliance professionals, research administrators, legal teams, and coding or reimbursement staff who monitor advisory opinions affecting clinical trial operations and affiliate relationships.
Why This Topic Matters
Advisory opinions can shape how organizations structure research support arrangements, affiliate billing practices, and patient access models while managing fraud and abuse risk. This summary helps readers quickly assess whether the opinion is relevant to research compliance, referral relationships, and support services in pediatric study programs.
What You Will Learn
- The general facts of the research organization and affiliate arrangement
- How OIG evaluated anti-kickback risk in a clinical research context
- What compliance considerations were relevant to the affiliate and patient-support structure
- Why the opinion was significant for pediatric research operations
Who Should Read This
- Health care compliance professionals
- Research administrators
- Healthcare attorneys
- Revenue cycle and billing staff
- Clinical trial operations teams
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com